However, the present study reveals that CAP treatment enhances the expression of PD-1 and PD-L1 in T cells and tumor cells, respectively, but reduces the expression of T cell cytokines (IFNγ, GZMB, and IL-2) that are associated with CTL functions and activity. The gene discussed is GZMB; the disease is neoplasm.